中国动脉硬化杂志2017，Vol.25Issue(10)：1076-1080,5.
非瓣膜性心房颤动患者围术期的抗凝治疗
Periprocedural anticoagulation in patients with nonvalvular atrial fibrillation
杨曙光1
作者信息
- 1. 解放军第88医院心内科,山东省泰安市271000
- 折叠
摘要
Abstract
Anticoagulant therapy is recommended for most patients with nonvalvular atrial fibrillation (NVAF) to reduce the risk of stroke and systemic embolism.Temporary interruption of oral anticoagulant drugs (OAC) in preparation for a procedure,is frequently necessary,most often to mitigate bleed risk with surgical or invasive procedures in these patients.In recent years,a lot of clinical studies related to periprocedural management of anticoagulant therapy for NVAF patients have been performed by specifical addressing:①whether or when anticoagulant therapy should be interrupted;②whether or how anticoagulant bridging with a parenteral agent should be performed;③when and how anticoagulant therapy should be restarted.Research status of periprocedural anticoagulation in NVAF patients will be reviewed in this article.关键词
非瓣膜性心房颤动/围术期/中断抗凝治疗/桥接抗凝治疗/重新抗凝治疗Key words
Nonvalvular atrial fribrillation/Periprocedure/Interruption of anticoagulation/Bridging anticoagulation/Reinitiation of anticoagulation分类
医药卫生引用本文复制引用
杨曙光..非瓣膜性心房颤动患者围术期的抗凝治疗[J].中国动脉硬化杂志,2017,25(10):1076-1080,5.
